Literature DB >> 10653427

Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion.

G K Shah1, S Sharma, M S Fineman, J Federman, M M Brown, G C Brown.   

Abstract

PURPOSE: To report arteriovenous adventitial sheathotomy for treatment of macular edema associated with branch retinal vein occlusion.
METHODS: Case reports with review. Five eyes of five patients with best-corrected visual acuity of less than 20/200 secondary to branch retinal vein occlusion had pars plana vitrectomy and arteriovenous adventitial sheathotomy and were followed postoperatively for a mean of 6.5 years (range, 5 to 7 years).
RESULTS: In four of five eyes, the best-corrected visual acuity improved to 20/30 to 20/70. In the remaining eye, visual acuity remained at finger counting secondary to macular ischemia.
CONCLUSION: Arteriovenous adventitial sheathotomy may be beneficial for select patients with poor vision secondary to branch retinal vein occlusion.

Entities:  

Mesh:

Year:  2000        PMID: 10653427     DOI: 10.1016/s0002-9394(99)00287-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

Review 1.  The management of retinal vein occlusion: is interventional ophthalmology the way forward?

Authors:  H Shahid; P Hossain; W M Amoaku
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion.

Authors:  M T Cahill; P K Kaiser; J E Sears; S Fekrat
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

3.  Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; William R Freeman; Hyoung Jun Koh
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

4.  Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; Hyo Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-19       Impact factor: 3.117

5.  Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study.

Authors:  Nicolas Feltgen; Julia Herrmann; Hansjuergen Agostini; Adel Sammain; Lutz L Hansen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-09       Impact factor: 3.117

6.  Angiographic findings in arteriovenous dissection (sheathotomy) for decompression of branch retinal vein occlusion.

Authors:  Thomas Kube; Nicolas Feltgen; Mona Pache; Julia Herrmann; Lutz Lothar Hansen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-03       Impact factor: 3.117

7.  Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment.

Authors:  Jérôme Charbonnel; Agnès Glacet-Bernard; Jean-François Korobelnik; Emilienne Nyouma-Moune; Constantin J Pournaras; Joseph Colin; Gabriel Coscas; Gisèle Soubrane
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 8.  [Retinal vein occlusions].

Authors:  S Dithmar; L L Hansen; F G Holz
Journal:  Ophthalmologe       Date:  2003-07       Impact factor: 1.059

9.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Authors:  Ingrid U Scott; Michael S Ip; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Clement K Chan; Victor H Gonzalez; Lawrence J Singerman; Michael Tolentino
Journal:  Arch Ophthalmol       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.